By Neal R. Swerdlow
This ebook describes the cutting-edge of therapy of schizophrenia and displays its improvement in 22 chapters written by means of top gurus within the box
Read or Download Behavioral Neurobiology of Schizophrenia and Its Treatment (Current Topics in Behavioral Neurosciences, Volume 4) PDF
Best biophysics books
The Nile: Origin, environments, limnology and human use (Monographiae Biologicae)
What have we learnt in regards to the Nile because the mid-1970s, the instant whilst Julian Rzóska determined that the time had come to post a entire quantity in regards to the biology, and the geological and cultural background of that fab river? And what alterations have in the meantime happened within the basin? The human popu- tion has greater than doubled, in particular in Egypt, but additionally in East Africa.
A entire one-source advisor to the most up-tp-date details on crimson blood mobilephone formation and the motion of recombinant human erythropoietins. subject matters coated comprise: erythropoiesis, recombinant protein discovery and creation, and remedy of sufferers with anemia. the latest theories in erythropoiesis (receptors, signaling), production, new formulations, and medical learn are mentioned.
- Biochemical Oscillations and Cellular Rhythms: The Molecular Bases of Periodic and Chaotic Behaviour
- Behavioral Neurobiology of Eating Disorders (Current Topics in Behavioral Neurosciences, Volume 6)
- Membrane Biophysics, 1st Edition
- Metastasis of Prostate Cancer (Cancer Metastasis - Biology and Treatment)
- Adaptation to Life at High Salt Concentrations in Archaea, Bacteria, and Eukarya (Cellular Origin, Life in Extreme Habitats and Astrobiology) (Cellular ... Life in Extreme Habitats and Astrobiology)
Additional resources for Behavioral Neurobiology of Schizophrenia and Its Treatment (Current Topics in Behavioral Neurosciences, Volume 4)
Sample text
26 The Cardiovascular and Metabolic Risk Profile of Subjects Entering the CATIE Schizophrenia Trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 4 The Impact of Antipsychotic Treatment on Cardiovascular and Metabolic Outcomes in the CATIE Schizophrenia Trial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Metabolic Outcomes . . . . . . . . . . . . . . . . . . . .
Annu Rev Neurosci 24:167 202 Moseley AM, Lanzarone S, Bosman JM, van Loo MA, de Bie RA, Hassett L, Caplan B (2004) Ecological validity of walking speed assessment after traumatic brain injury: a pilot study. J Head Trauma Rehabil 19:341 348 Murray CL, Lopez AD (1996) The global burden of disease. Harvard University Press, Cambridge, MA Naber D, Karow A (2001) Good tolerability equals good results: the patient’s perspective. Eur Neuropsychopharmacol 11(Suppl 4):S391 S396 Nakagami E, Xie B, Hoe M, Brekke JS (2008) Intrinsic motivation, neurocognition and psycho social functioning in schizophrenia: testing mediator and moderator effects.
2 Hypotheses on Schizophrenia and Metabolic Risk, and Adiposity Independent Drug Effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 6 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Abstract Schizophrenia patients have high prevalence of cardiovascular (CV) disease risk factors and high CV mortality, with increasing concern over the contribution of antipsychotic medications to cardiometabolic risk.